VBIZF (Viva Biotech Holdings) Price-to-Owner-Earnings : (As of Dec. 11, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Price-to-Owner-Earnings?

As of today (2024-12-11), Viva Biotech Holdings's share price is $0.1136. Viva Biotech Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Viva Biotech Holdings's Price-to-Owner-Earnings or its related term are showing as below:

During the past 8 years, the highest Price-to-Owner-Earnings of Viva Biotech Holdings was 523.33. The lowest was 135.56. And the median was 254.44.

VBIZF's Price-to-Owner-Earnings is not ranked ^*
in the Biotechnology industry.
Industry Median: 31.44
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-12-11), Viva Biotech Holdings's share price is $0.1136. Viva Biotech Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.01. Therefore, Viva Biotech Holdings's PE Ratio (TTM) for today is At Loss.

As of today (2024-12-11), Viva Biotech Holdings's share price is $0.1136. Viva Biotech Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.00. Therefore, Viva Biotech Holdings's PE Ratio without NRI for today is At Loss.

During the past 8 years, Viva Biotech Holdings's highest PE Ratio without NRI was 58.32. The lowest was 0.00. And the median was 22.12.

Viva Biotech Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Viva Biotech Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Price-to-Owner-Earnings Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

Get a 7-Day Free Trial

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Price-to-Owner-Earnings	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Viva Biotech Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, Viva Biotech Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viva Biotech Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's Price-to-Owner-Earnings falls into.

Viva Biotech Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Viva Biotech Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	0.1136	/	-0.01
	=

Viva Biotech Holdings (OTCPK:VBIZF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Viva Biotech Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (OTCPK:VBIZF) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

01873:Hong Kong VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.